Literature DB >> 27928276

Changes in Visual Function over Time in Koreans with Non-arteritic Anterior Ischaemic Optic Neuropathy.

Ji Woong Chang1, Jin Choi2, Young Suk Yu3, Seong-Joon Kim3.   

Abstract

Non-arteritic anterior ischaemic optic neuropathy (NAION) causes severe visual loss in elderly patients. However, there are not much data of clinical course of NAION in Asian patients. To evaluate changes in visual acuity and visual field defects associated with non-arteritic anterior ischaemic optic neuropathy (NAION) among Korean patients, the medical records of 50 eyes from 43 patients with NAION patients seen from 1989 to 2011 were reviewed. A significant change in visual acuity was defined as a three-line change in Snellen acuity. Visual field defects were evaluated with Goldmann perimetry. Changes in the visual field were evaluated using the grid method. Thirty-eight percent of eyes showed improvement, 54% showed no change, and 8% showed deterioration of visual acuity at the last follow-up. Thirty-four percent of eyes showed improvement, 54% showed no change, and 12% showed deterioration of the visual field at the last follow-up. Most improvement in visual acuity occurred during the first month after the initial visit and in visual field between the first and third months of follow-up. The prognosis of visual acuity in association with NAION was worse in Korean patients as compared with Western studies. However, improved prognosis of visual field defects might come from the use of different methods for evaluation of the visual field.

Entities:  

Keywords:  Ischaemic optic neuropathy; visual acuity; visual fields

Year:  2014        PMID: 27928276      PMCID: PMC5122913          DOI: 10.3109/01658107.2013.855240

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  23 in total

1.  Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial.

Authors: 
Journal:  Arch Ophthalmol       Date:  1996-11

2.  Incidence of nonarteritic anterior ischemic optic neuropathy.

Authors:  M G Hattenhauer; J A Leavitt; D O Hodge; R Grill; D T Gray
Journal:  Am J Ophthalmol       Date:  1997-01       Impact factor: 5.258

3.  Ischaemic papillopathy. Clinical and fluorescein aniographic review of forty cases.

Authors:  E M Eagling; M D Sanders; S J Miller
Journal:  Br J Ophthalmol       Date:  1974-12       Impact factor: 4.638

4.  Blood supply of the optic nerve head and its role in optic atrophy, glaucoma, and oedema of the optic disc.

Authors:  S S Hayreh
Journal:  Br J Ophthalmol       Date:  1969-11       Impact factor: 4.638

5.  Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial examination.

Authors:  Sohan Singh Hayreh; Bridget Zimmerman
Journal:  Arch Ophthalmol       Date:  2005-11

6.  Ischaemic optic neuropathy. The clinical profile and history.

Authors:  D R Boghen; J S Glaser
Journal:  Brain       Date:  1975-12       Impact factor: 13.501

7.  Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles.

Authors:  J F Rizzo; S Lessell
Journal:  Arch Ophthalmol       Date:  1991-12

8.  The ischemic optic neuropathy decompression trial (IONDT): design and methods.

Authors: 
Journal:  Control Clin Trials       Date:  1998-06

9.  Anterior ischemic optic neuropathy in patients younger than 50 years.

Authors:  Pisit Preechawat; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Am J Ophthalmol       Date:  2007-09-14       Impact factor: 5.258

10.  Nonarteritic anterior ischemic optic neuropathy: natural history of visual outcome.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2007-08-15       Impact factor: 12.079

View more
  1 in total

1.  Factors Associated With Visual Acuity in Non-arteritic Ischemic Optic Neuropathy Patients: A Five-Year Cross-Sectional Study.

Authors:  Parinee Kemchoknatee; Chotika Singhakul; Duanghathai Tangon; Thansit Srisombut
Journal:  Cureus       Date:  2022-09-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.